![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
C Kule, O Ondrejickova and K Verner
Department of Cellular and Molecular Physiology, Pennsylvania State University College of Medicine, Hershey 17033.
We have investigated the effect of doxorubicin (Adriamycin) on the yeast Saccharomyces cerevisiae. Drug treatment was found to be cytotoxic to wild-type strains, in a concentration-dependent manner, whereas a petite mutant lacking the cytochrome oxidase (EC 1.9.3.1) subunit IV gene was resistant to doxorubicin. Transformation of the doxorubicin-resistant mutant with a yeast in vivo expression vector harboring the cytochrome oxidase subunit IV gene restored both respiration and sensitivity to doxorubicin. Another petite strain, with a mutation in the mitochondrial adenine nucleotide translocator (pet9), did not display doxorubicin resistance. However, in contrast to the subunit IV mutant, it possesses a functional respiratory chain. We also compared the cytotoxic effect of doxorubicin with those of daunorubicin and mitoxantrone in yeast. We found comparable levels of cytotoxicity for doxorubicin and daunorubicin, which were significantly greater than that for mitoxantrone. Finally, we constructed a yeast strain that overexpresses manganese superoxide dismutase (EC 1.15.1.1), an antioxidant enzyme present in mitochondria. Overexpression of manganese superoxide dismutase protected significantly against doxorubicin and daunorubicin cytotoxicity but only slightly against mitoxantrone cytotoxicity. Collectively, our results provide direct in vivo evidence that superoxide radicals participate in doxorubicin- and daunorubicin- induced cytotoxicity in yeast. Furthermore, these results indicate that mitochondrial respiration is a crucial factor in anthracycline, and perhaps mitoxantrone, cytotoxicity in yeast.
This article has been cited by other articles:
|
|
 |
|
  T. Furuchi, T. Takahashi, S. Tanaka, K. Nitta, and A. Naganuma Functions of yeast helicase Ssl2p that are essential for viability are also involved in protection from the toxicity of adriamycin Nucleic Acids Res., May 11, 2004; 32(8): 2578 - 2585. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Buschini, P. Poli, and C. Rossi Saccharomyces cerevisiae as an eukaryotic cell model to assess cytotoxicity and genotoxicity of three anticancer anthraquinones Mutagenesis, January 1, 2003; 18(1): 25 - 36. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Kim, H. Sikder, and K. K. Singh A colony color method identifies the vulnerability of mitochondria to oxidative damage Mutagenesis, September 1, 2002; 17(5): 375 - 381. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. K. Singh, B. Sigala, H. A. Sikder, and C. Schwimmer Inactivation of Saccharomyces cerevisiae OGG1 DNA repair gene leads to an increased frequency of mitochondrial mutants Nucleic Acids Res., March 15, 2001; 29(6): 1381 - 1388. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. L. Forrest, B. Gonzalez, W. Tseng, X. Li, and J. Mann Human Carbonyl Reductase Overexpression in the Heart Advances the Development of Doxorubicin-induced Cardiotoxicity in Transgenic Mice Cancer Res., September 1, 2000; 60(18): 5158 - 5164. [Abstract] [Full Text]
|
|
|
|
 |
|
 S. Patel, A. U. Sprung, B. A. Keller, V. J. Heaton, and L. M. Fisher Identification of Yeast DNA Topoisomerase II Mutants Resistant to the Antitumor Drug Doxorubicin: Implications for the Mechanisms of Doxorubicin Action and Cytotoxicity Mol. Pharmacol., October 1, 1997; 52(4): 658 - 666. [Abstract] [Full Text]
|
|
 |
 |
 |
|
 |
 |
 |
